D.KleinS.BackhausJ.BlankS.et al
The new agreements are in effect until March 31, 2023 Lexaria Granted Important New Oral Nicotine Patent March 08, 2022 Newest granted patent expands worldwide patent portfolio to 24 Lexaria Reports Potentially Ground Breaking Findings in Sildenafil Animal Study February 2, 2022 DehydraTECH sildenafil delivered 74% more drug at 4 minutes, than the control Lexarias DehydraTECH-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2 December 8, 2021 Testing confirms that DehydraTECH-processed cannabidiol reduces arterial stiffness, potentially broadening application to treatment of cardiovascular and other diseases beyond hypertension
Added to lightweight formulations designed for daily skincare routines
Sa B, Maristany A, Subramaniam A, et al
Furthermore, direct GSSG delivery into cells via microinjection induces neural cell death via a 12-lipoxygenase pathway 36